Cats are not small dogs: is there an immunological explanation for why cats are less affected by arthropod-borne disease than dogs?
Parasites & Vectors volume 9, Article number: 507 (2016)
It is widely recognized that cats appear to be less frequently affected by arthropod-borne infectious diseases than dogs and share fewer zoonotic pathogens with man. This impression is supported by the relative lack of scientific publications related to feline vector-borne infections. This review explores the possible reasons for the difference between the two most common small companion animal species, including the hypothesis that cats might have a genetically-determined immunological resistance to arthropod vectors or the microparasites they transmit. A number of simple possibilities might account for the lower prevalence of these diseases in cats, including factors related to the lifestyle and behaviour of the cat, lesser spend on preventative healthcare for cats and reduced opportunities for research funding for these animals. The dog and cat have substantially similar immune system components, but differences in immune function might in part account for the markedly distinct prevalence and clinicopathological appearance of autoimmune, allergic, idiopathic inflammatory, immunodeficiency, neoplastic and infectious diseases in the two species. Cats have greater genetic diversity than dogs with much lower linkage disequilibrium in feline compared with canine breed groups. Immune function is intrinsically related to the nature of the intestinal microbiome and subtle differences between the canine and feline microbial populations might also impact on immune function and disease resistance. The reasons for the apparent lesser susceptibility of cats to arthropod-borne infectious diseases are likely to be complex, but warrant further investigation.
In recent years there has been renewed interest in investigating the epidemiology, clinicopathological mechanisms and phylogeny of the causative organisms of canine arthropod-borne infectious diseases. Molecular and immunological tools have allowed the discovery of novel pathogens, the reclassification of other microorganisms and provided the ability to undertake surveillance studies that track the geographical movement of these agents and their arthropod vectors. Some of these studies are performed from a ‘One Health’ perspective; with the recognition that many of the canine arthropod-borne infections are zoonotic or that the dog may act as a reservoir or sentinel for human infection . As our companion dogs so closely share our lifestyle and indoor environment, there is recognition that control of these diseases must involve strategies to prevent infection in both people and dogs. One of the strongest cases for a One Health approach to these diseases is that of zoonotic visceral leishmaniosis, where prevention of human infection necessitates control of infection in the canine reservoir in addition to management of the sand fly vector .
But what of the other important small companion animal species - the domestic cat? The cat is ubiquitous in both developed and developing societies and equally shares the human environment with the dog . Where numbers of small companion animals are estimated, it is clear that there are similar populations of pet dogs and cats living in human households [4–6] and in developing countries there are significant, but unquantified, populations of stray or community-owned dogs and cats. For example, in the USA in 2011 there were an estimated 69 million dogs living in 36.5 % of households and 74 million cats in 30.4 % of households . In the UK in the same year, there were an estimated 11.5 million dogs in 30 % of households and 10 million cats in 23 % of households . But despite the popularity of the cat as a companion animal, there is relatively little knowledge about the prevalence or nature of feline arthropod-borne infectious diseases. Recent reviews cover these infections [7, 8], but it is clear that we understand less about the same agents in cats compared with dogs. Anecdotally, it is often suggested that cats are less affected by arthropod-borne diseases than dogs and that this may be attributed to some form of natural resistance to these pathogens or their vectors. This would appear to be supported by a relatively low prevalence of most infections recorded in cats in areas in which the diseases are endemic [9–12]. The aim of this review is to explore this hypothesis and examine the evidence that underpins this proposal.
Do cats get less arthropod-borne infectious disease and if so, why?
A recent study suggests that the number of zoonoses shared between man and different domestic animal species is determined by the time since that species was domesticated. The dog shares the most infectious diseases with people as dogs were first domesticated at least 15,000 years ago. In contrast, feline diseases shared with man are suggested to be only one third of the number of those of the dog because domestication of the cat occurred 10,000 years ago .
If one considers the prevalence of the major arthropod-borne infectious diseases of small companion animals, a ‘broad brush’ perspective would suggest that cats are less affected by these conditions than dogs (Table 1). To assess this in a somewhat more robust fashion, a search of the Thomson Reuters Web of Science database (performed in May 2016) was performed using the search terms ‘dog AND arthropod borne disease’, ‘cat AND arthropod borne disease’, ‘dog AND vector borne disease’ and ‘cat AND vector borne disease’. Between 1997 and May 2016, this search revealed 496 publications for the dog and 175 for the cat, with marked rises in the number of publications related to both species from 2008 onwards.
So what could be the reasons for the apparent difference in the prevalence of canine and feline arthropod-borne diseases? There are many possibilities and a number of these are far more pragmatic than the more interesting hypothesis of some form of natural resistance of the feline species to these diseases. The fewer publications may simply reflect the fact that less research is performed on the feline diseases, because there is less funding available for feline research and consequently there are fewer commercially available diagnostic tests or published research methodologies for the cat. The research community that focuses on feline arthropod-borne infectious diseases is much smaller than that which studies the equivalent disorders in the dog.
An alternative hypothesis might be that cats are simply taken for veterinary attention less often than dogs and the diseases are consequently less often diagnosed and recorded. Fewer available cases of a particular disease or infection makes it much more challenging to aquire a sufficient number of cases for a meaningful research investigation. Owner spend on preventative healthcare is thought to be less for cats than for dogs. For example, it has been suggested that cats are less frequently vaccinated than dogs. A UK survey of 3103 cat owners showed that 69 % of cats were currently vaccinated, but the survey likely selected for more dedicated cat owners . In the USA, 81 % of dog-owning households made at least one veterinary visit in 2011 spending an average of $227 per dog, but only 55 % of cat owners sought veterinary attention, spending an average of $90 per cat . Lesser preventative healthcare in turn may relate simply to the relatively independent nature and lifestyle of cats, the fact that cats are better able to ‘hide’ the signs of illness, the lesser value often placed on cats by society and the practical difficulties in transporting a cat for veterinary attention. Preventative healthcare veterinary visits also appear to decline with increasing age of the cat .
The feline lifestyle per se may also impact on the prevalence of arthropod-borne infections. In some countries, many more cats have an indoor only lifestyle that of course minimizes the risk of exposure to arthropods [14, 16]. But, even where cats have outdoor access, does their behaviour also limit arthropod exposure? Are cats better able to avoid questing ticks or sandfly bites or does their more fastidious grooming behaviour mean that they are likely to dislodge ticks before transmission of a microparasite? Or is it possible that cats have a natural chemical signal that provides resistance to arthropod bites as do individual humans ?
However, the most interesting hypothesis would be that cats have a natural, genetically controlled immunological resistance to arthropods and the microorganisms they transmit. Perhaps the feline immune system is less susceptible to the range of immunomodulatory salivary proteins contained within arthropod saliva [18–22] and the cat is more competent at generating protective or sterilizing immune responses to arthropod-borne pathogens. The remainder of this review will focus on the feline immune system and whether there are differences to that of the dog that might account for an apparent difference in susceptibilty to these pathogens.
Are there differences between the canine and feline immune systems?
Only 30 years ago the study of canine and feline immunology was in its infancy, with few reagents and techniques limiting the ability to investigate humoral and cellular immune responses. The discovery of the feline immunodeficiency virus and the suggestion that the cat was an appropriate model for human immuodeficiency virus infection led to a period of research funding and development of immunological methods throughout the 1990s [23–25]. Shortly after there was similar development of reagents for canine immunology and interest in exploring canine immunogenetics and the association of canine diseases with genes of the major histocompatibility complex (MHC) [26–28]. The most significant breakthrough in canine immunology came with publication of the canine genome in 2005 , which enabled the rapid development of molecular means of detecting and characterizing a wide range of canine cytokines, chemokines, pattern recognition receptors and lymphocyte subsets. Similar methodology was developed for feline immunology, although the first complete feline genome was not published until 2014 .
Broadly assessing the published literature on canine and feline immunology, there are no simple significant differences between the two species . Both species have the same range of lymphoid subsets, with T helper (Th) 1, Th2, Th17 and T regulatory (Treg) cell function indentified in each by expression of the same range of cytokines and key molecules such as forkhead box P3 (FoxP3; considered as a marker of Treg cells). Both species express the same range of pattern recognition receptors (Toll-like receptors, nucleotide-binding oligomerization domain containing [NOD]-like receptors and others) and have the same spectrum of antigen presenting cells. Less is known about phagocytic cell function and the complement pathways, although there is little reason to suspect any significant differences.
There may, however, be subtle differences in canine and feline immunoglobulins (Igs). The dog has four IgG subclasses which are functionally equivalent to those of man [32, 33]. In contrast, only three IgG subclasses are recognized in the cat . Both species have IgM and IgE antibodies, although IgD has only been identified formally in the dog . There may also be differences in IgA - both species have IgA, but in the dog four genetic variants of the molecule are reported , but there have been no equivalent studies of feline IgA.
Do dogs and cats have different susceptibility to disease?
Although dogs and cats appear to have generally similar immune systems, there are distinct species differences in susceptibility to or clinical presentation of diseases that are caused by or that involve the immune system. This might suggest that although the components of the immune system are equivalent in both species, these components might interact differently, leading to distinct immunological outcomes.
Autoimmune diseases, in which the immune system reacts inappropriately against self tissue antigens, are multifactorial in pathogenesis, but involve immune imbalance - particularly with respect to impairment in the function of natural regulatory T cells . A wide spectrum of autoimmune diseases is well documented and relatively common in the dog and these diseases often closely mimic the equivalent disorders in man [38, 39]. Canine autoimmune diseases are associated with autoantibodies and/or autoreactive cytotoxic T lymphocytes and reduced Treg function . The diseases are breed-associated and often are familial and, like in people, there are clear links to the inheritance of particular susceptibility haplotypes of MHC genes . In contrast, autoimmune diseases are relatively uncommon in the cat and there are no clear breed or familial associations, and no genetic basis is described.
Allergic diseases also present distinctly in dogs and cats. Cutaneous allergy is common in the dog (e.g. atopic dermatitis, flea allergy dermatitis) and food-associated allergy affecting the gastrointestinal tract is also increasingly recognized. However, allergic respiratory disease (i.e. eosinophilic bronchopneumopathy; EBP) is uncommon in dogs. Canine allergic diseases (particularly atopic dermatitis) are breed associated and familial [41–43] and are related to the function of induced regulatory T cells . Again in contrast, feline allergy is relatively poorly defined and differs to the canine diseases in prevalence and presentation. Feline asthma is probably more common than canine EBP, yet atopic dermatitis may be more common in dogs compared with cats . Feline cutaneous atopy has a spectrum of clinical presentation (the eosinophilic granuloma complex) that is distinctly different to the lesions of canine atopic dermatitis [46, 47].
Idiopathic inflammatory diseases affect both species, but again with some unique species differences. For example, both dogs and cats suffer from idiopathic inflammatory bowel disease (IBD); in particular, lymphoplasmacytic enteritis. In both species, the immunopathogenesis of IBD is proposed to reflect a combination of dysbiosis of the intestinal microbiome, intestinal barrier dysfunction and underlying immunological imbalance reflected in reduced activity of regulatory T cells permiting overactivity of Th1 and Th17 effector cells. However, there are differences in baseline intestinal immunity and in the immunopathology of IBD in dogs and cats. Cats have higher numbers of small intestinal intraepithelial lymphocytes than dogs [48, 49], but only canine enterocytes show consitutive expression of MHC class II molecules . Dogs with IBD have a significant increase in the numbers of T cells and plasma cells infiltrating the intestinal lamina propria , which does not occur in cats ; however, cats with IBD have induced expression of MHC class II molecules on enterocytes. Cytokine gene expression studies within lesional tissue have consistently failed to demostrate differences between normal and inflamed canine intestine [52, 53], but in cats, increased expression of proinflammatory, Th1- and Treg-related cytokines has been shown . Canine IBD more clearly has a genetic component with strong breed predispositions and genetic associations; for example the links between polymorphisms in Toll-like receptor genes and IBD in German shepherd dogs [55, 56]. No such associations are reported for feline IBD, but cats more frequently have concurrent hepatic and pancreatic inflammatory disease (‘triaditis’) than dogs . Finally, although unproven, it has long been suggested that feline chronic intestinal inflammation may be a precursor to alimentary lymphoma , but this transition is less clearly recognized in the dog.
Primary inherited immunodeficiency diseases markedly differ between dogs and cats. In the dog, there is a spectrum of some 30 distinct breed-related putative immunodeficiency disorders, although only four of these have been characterized as to the genetic mutation responsible for the disease (i.e. the canine leucocyte adhesion deficiency, canine severe combined immunodeficiency [X-linked and not], the trapped neutrophil syndrome and the grey collie syndrome) [39, 59]. In distinct contrast, only three primary immunodeficiency diseases are reported in the cat: Pelger-Huet anomaly, Chediak-Higashi syndrome and a genetic mutation resulting in athymic and hairless Birman kittens [39, 60].
Dogs and cats also develop different spectra of neoplastic diseases and it is now clear that the immune system plays a crucial role in determining the biological behaviour of tumours - in particular, the effects of tumour-infiltrating Tregs and tumour-associated macrophages that impair anti-tumour immune responses and promote metastasis via tissue remodelling and neoangiogenesis [61–63]. With the recent availability of large cancer registries for both species [64, 65], we can now appreciate some of the species differences in the type, distribution and biological behaviour of canine and feline tumours. Although skin tumours are most commonly documented in both species, the relative occurrence of other neoplasms is not consistent between dogs and cats [64, 65]. Some examples to illustrate these differences would include: the feline injection site sarcoma  which is almost never reported in the dog, haemangiosarcoma which arises commonly in the spleen or heart of the dog  and only rarely in the skin of the cat, the spectum of histiocytic tumours of the dog [67, 68] which are almost unknown in the cat, the greater malignancy of feline compared with canine mammary tumours , but the relatively benign behaviour of feline versus canine cutaneous mast cell tumour . There are again clear genetic associations for canine tumours (e.g. haemangiosarcomas in German shepherd dogs, histiocytic tumours in Bernese Mountain dogs and flat coated retrievers, mast cell tumours in Boxers and Labradors)  that are not recognized in the cat.
Finally, dogs and cats are susceptible to different spectra of infectious diseases other than the arthropod-borne infections. For example, dogs are more commonly affected by bacterial pyoderma , leptospirosis [72–74] and systemic or non-invasive upper respiratory fungal infections  than cats, but cats are increasingly reported with mycobacterial infections  or invasive upper respiratory tract fungal infections . Cats are much more often affected by a range of viral infections than dogs (e.g. feline leukaemia virus, feline immunodeficiency virus, feline calicivirus, feline herpesvirus type 1 and feline infectious peritonitis virus). Despite the global occurrence of feline retrovirus infections there is no clear evidence for a canine retrovirus although endogenous canine retrovirus sequence within the canine genome shows that such viruses existed before the evolutionary divergence of the dog and the red fox [78, 79]. Cats appear susceptible to experimental infection with influenza viruses [80, 81] and the SARS coronavirus  and may sometimes develop clinical signs related to these infections, but this species is often considered relatively resistent to natural influenza virus infection. In contrast, dogs develop clinical disease when infected with influenza A viruses that originated in horses (H3N8 virus) or birds (H3N2 virus) . Canine distemper virus and canine adenovirus infections involve other species, but not domestic cats [84, 85], while canine parvovirus type 2 appears to move back and forth between cats and dogs .
Is it possible to tie all of these elements of immunity and immune response together to model the differences between dogs and cats (Fig. 1)? For example do dogs have an immune system dominated by Th2 immune responses (involving antibody production) that explains their relative susceptibility to allergic diseases and autoantibody-mediated diseases, and are such diseases less common in cats because they mount an opposing Th1 immune response (involving cell-mediated immunity with cytotoxic responses driven by the cytokine interferon [IFN]-γ)? At this level, such a model might work, but it falls down when one considers the relative frequency of viral infections in cats - which should not occur if they had a background of protective Th1 immunity. In the case of arthropod-borne infectious diseases, such a Th1 versus Th2 model might be proposed to explain the dichotomy between cats and dogs. If dogs truly were a Th2-dominated species they might logically have greater susceptibility to vector-borne pathogens that often require a Th1 immune response to control or sterilize the infection.
A difference in immune responsiveness has been proposed for leishmaniosis. It is now well known that the resistance or susceptibility of a dog to Leishmania infantum infection and clinical disease is determined by the immune response; and that this is likely under genetic control . A resistant dog mounts a Th1 immune response in which IFN-γ signals infected macrophages to destroy intracellular amastigotes, but Treg-derived interleukin (IL)-10 prevents sterilization of the infection and maintains that dog as a reservoir of L. infantum. This control of the infection limits the clinicopathological damage. In contrast, a susceptible dog mounts an inappropriate Th2 immune response in which cytokines such as IL-4 and IL-13 activate B lymphocytes, leading to hypergammaglobulinaemia, autoantibody and immune complex formation. Such dogs develop severe life-threatening clinical disease, largely related to secondary immunopathology . A recent review has proposed that the feline immune response to L. infantum may differ from that of the dog. Although some cats develop severe clinical disease following L. infantum infection , this species is suggested to have a ‘natural immunity’ that often allows spontaneous resolution of lesions post infection due to effective Th1 immunity. However, following such resolution, there is seroconversion and antibody titre has been linked to control of infection with reduced positivity in polymerase chain reaction testing . These possible species differences are intriguing and should be further explored.
Are there genetic differences between dogs and cats?
Can all of these disease susceptibility and immune function differences between dogs and cats be explained by their relative genetics? The most important genes regulating immune responsiveness are those of the MHC. Dogs and cats are unusual amongst mamallian species in having this gene complex spread over two chromosomes - a break that occurred before the divergence of these species over 55 million years ago . The cat also appears to lack one of the loci within the MHC class II gene cluster (the DQ gene) , the implication of which might be that cats have more restricted possibilities for antigen presentation. We know that inbreeding has led to limited genetic diversity within the different breeds of dog [91–94] and that within breeds there is a high linkage disequilibrium (i.e. non-random association of alleles at different loci on chromosomes) and restricted MHC type. This means that the dog is a particularly valuable model for genetic studies of disease. In contrast, there is much less linkage disequilibrium in cats and feline breeds compared with the dog . Such restricted genetic diversity might help explain the susceptibility of dogs to certain diseases, including potentially, the arthropod-borne infectious diseases.
Are there differences in regulation by the canine and feline microbiome?
It is increasingly recognized that immune development, immune function and susceptibility to disease is regulated by the microbiome, particularly that of the intestinal tract. Particular constituents of the microbiome are powerful inducers of regulatory T cells that control autoimmune and allergic disease, but other organisms or a changed balance in the microbiome (i.e. dysbiosis) might trigger pathological immune reactions within the intestinal mucosa and other organs [96, 97]. Therefore, if immune function is so closely regulated by the microbiome, could differences in canine and feline immunity lie at this level?
Over 20 years ago, it was proposed that dogs and cats had distinct differences in the bacterial content of the small intestine. Cultures of duodenal juice revealed 102 to 105 colony forming units (cfu) of bacteria in the canine proximal small intestine, but 105 to 108 cfu in the equivalent area of the feline intestine . It was suggested that these differences might impact on the relative occurrence of inflammatory enteropathy in the two species. However, more recently we appreciate that such culture techniques were highly inacurate and key differences likely relate to the composition rather than the number of organisms within the microbiome.
Recent studies have begun to characterize the canine and feline intestinal microbiomes. It seems that individual animals have very distinctive and very stable microbial compositions , but that differences do exist between dogs and cats, both with respect to the type of organisms and with the metagenomic function (i.e. metabolic profiles) of those organisms . Further investigations have shown broad similarity in the major families of bacteria within the dog and cat microbiome, but cats having much greater diversity in the fungal components of the microbiome relative to dogs . There are also differences between the species in disease; intestinal dysbiosis in canine IBD is characterized by increased representation of Clostridium perfringens, but this increase is not seen in the intestinal microbiome of cats with IBD [102, 103].
Although dogs and cats largely share equivalent immune systems, there are clear differences between the species as to how the elements of the immune system interact – creating species diversity in susceptibility to, and clinicopathological expression of, immune-mediated, neoplastic and infectious diseases. No simple immunological model can summarize these differences in immune function, but immunity might be regulated by distinct genetic backgrounds and potentially by differences in the intestinal microbiome in dogs and cats. If cats are really less susceptible than dogs to arthropod-borne infectious diseases, it remains possible that such resistance relates to differential immune function. However, there are still much simpler explanations that might account for the species difference in occurrence of vector-borne diseases and much work is still required to characterize more accurately the true prevalence and clinical significance of these infections in the cat.
Colony forming units
Major histocompatibility complex
Nucleotide oligomerization domain
T helper cell
Regulatory T cell
Day MJ. One health: the importance of companion animal vector-borne diseases. Parasit Vectors. 2011;4:49.
Palatnik-de-Sousa CB, Day MJ. One health: the global challenge of epidemic and endemic leishmaniasis. Parasit Vectors. 2011;4:197.
Chomel BB, Sun B. Zoonoses in the bedroom. Emerg Inf Dis. 2011;17:167–72.
American Veterinary Medical Association. US pet ownership and demographics sourcebook (2012). Schaumburg: AVMA; 2012.
Day MJ. One health: bringing together human and veterinary medicine. Eur J Comp Anim Pract. 2014;24:74–80.
Murray JK, Gruffydd-Jones TJ, Roberts MA, Browne WJ. Assessing changes in the UK pet cat and dog populations: numbers and household ownership. Vet Rec. 2015;177:259.
Shaw SE, Birtles RJ, Day MJ. Arthropod-borne infectious diseases of cats. J Feline Med Surg. 2002;3:193–209.
Day MJ. Arthropod-borne infectious diseases of the dog and cat. 2nd ed. London: CRC Press; 2016.
Tabar M-D, Altet L, Francino O, Sanchez A, Ferrer L, Roura X. Vector-borne infections in cats: molecular study in Barcelona area (Spain). Vet Parasitol. 2008;151:332–6.
Vilhena H, Martinez-Diaz VL, Cardoso L, Vieira L, Altet L, Francino O, et al. Feline vector-borne pathogens in the north and centre of Portugal. Parasit Vectors. 2013;6:99.
Pantchev N, Globokar V, Rhovec M, Pluta S, Straubinger RK. Seropositivity of Borrelia burgdorferi in a cohort of symptomatic cats from Europe based on a C6-peptide assay with discussion of implications in disease aetiology. Berl Munch Tierarztl Wochenschr. 2016;129:333–9.
Persichetti MF, Solano-Gallego L, Serrano L, Altet L, Reale S, Masucci M, et al. Detection of vector-borne pathogens in cats and their ectoparasites in southern Italy. Parasit Vectors. 2016;9:247.
Morand S, McIntyre KM, Baylis M. Domesticated animals and human infectious diseases of zoonotic origins: domestication time matters. Infect Genet Evol. 2014;24:76–81.
Harbacher G, Gruffydd-Jones T, Murray J. Use of a web-based questionnaire to explore cat owner’s attidutes towards vaccination in cats. Vet Rec. 2010;167:122–7.
Toribio J-A, Norris JM, White JD, Dhand NK, Hamilton SA, Malik R. Demographics and husbandry of pet cats living in Sydney, Australia: results of cross-sectional survey of pet ownership. J Feline Med Surg. 2009;11:449–61.
Clancy EA, Moore AS, Bertone ER. Evaluation of cat and owner characteristics and their relationships to outdoor access of owned cats. J Am Vet Med Assoc. 2003;222:1541–5.
Fernández-Grandon GM, Gezan SA, Armour JAL, Pickett JA, Logan JG. Heritability of attractiveness to mosquitoes. PLoS One. 2015;10:e0122716.
Day MJ. The immunopathology of canine vector-borne diseases. Parasit Vectors. 2011;4:48.
Wikel S. Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment. Front Microbiol. 2013;4:337.
Kazimirova M, Stibraniova I. Tick salivary compounds: their role in modulation of host defences and pathogen transmission. Front Cell Infect Microbiol. 2013;3:43.
Tirloni L, Reck J, Soares Terra RM, Martins JR, Mulenga A, Sherman NE, et al. Proteomic analysis of cattle tick Rhipicephalus (Boophilus) microplus saliva: a comparison between partially and fully engorged females. PLoS One. 2014;9:e94831.
Mason LMK, Veerman CC, Geijtenbeek TBH, Hovius JWR. Menage a trois: Borrelia, dendritic cells and tick saliva interactions. Trends Parsitol. 2014;30:95–103.
Pedersen NC, Ho EW, Brown ML, Yamamoto JK. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 1987;235:790–3.
Willett BJ, Jarrett O. Feline immunology and immunodeficiency. Oxford: Oxford University Press; 1995.
Meister RK, Tagliner K, Haverson K, Strohminger N, Mathes LE. Progress in the discovery and definition of monoclonal antibodies for use in feline research. Vet Immunol Immunopathol. 2007;119:38–46.
Cobbold S, Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens. 1994;43:137–54.
Kenndey LJ, Carter SD, Barnes A, Bell S, Bennett D, Ollier B, et al. Interbreed variation of DLA-DRB1, DQA1 alleles and haplotypes in the dog. Vet Immunol Immunopathol. 1999;69:101–11.
Schuberth H-J, Kucinskiene G, Chu R-M, Faldyna M. Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes. Vet Immunol Immunopathol. 2007;119:47–55.
Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature. 2005;438:803–19.
Montague MJ, Li G, Gandolfi B, Khan R, Aken BL, Searle SMJ, et al. Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication. Proc Natl Acad Sci USA. 2014;111:17230–5.
Day MJ, Schultz RD. Veterinary immunology: principles and practice. London: CRC Press; 2014.
Mazza G, Whiting AH, Day MJ, Duffus WPH. The preparation of monoclonal antibodies specific for the subclasses of canine immunoglobulin G. Res Vet Sci. 1994;57:140–5.
Bergeron LM, McCandless EE, Dunham S, Dunkle B, Zhu Y, Shelly J, et al. Comparative functional characterization of canine IgG subclasses. Vet Immunol Immunopathol. 2014;157:31–41.
Strietzel CJ, Bergeron LM, Oliphant T, Mutchler VT, Choromanski LJ, Bainbridge G. In vitro functional characterization of feline IgGs. Vet Immunol Immunopathol. 2014;158:214–23.
Rogers KA, Richardson JP, Scinicariello F, Attanasio R. Molecular characterization of immunoglobulin D in mammals: immunoglobulin heavy constant delta genes in dogs, chimpanzees and four old world monkey species. Immunology. 2006;118:88–100.
Peters IR, Helps CR, Lait PL, Harris C, Lee AC, Jones CA, et al. Detection of allelic variants of the canine IGHA gene by fluorescence resonance energy transfer melting temperature examination. J Immunol Methods. 2005;304:60–7.
Rosenblum MD, Remedios KA, Abbas AK. Mechanisms of human autoimmunity. J Clin Invest. 2015;125:2228–33.
Gershwin LJ. Autoimmune diseases in small animals. Vet Clin Small Anim. 2010;40:439–57.
Day MJ. Clinical immunology of the dog and cat. 2nd ed. London: CRC Press; 2012.
Kennedy LJ, Ollier WER, Marti E, Wagner JL, Storb RF. Canine immunogenetics. In: Ostrander EA, Ruvinsky A, editors. The genetics of the dog. 2nd ed. Oxford: CABI; 2012. p. 91–126.
Clercx C, Peeters D, Snaps F, Hansen P, McEntee K, Detilleux J, et al. Eosinophilic bronchopneumopathy in dogs. J Vet Intern Med. 2000;14:282–91.
Wilhem S, Kovalik M, Favrot C. Breed-associated phenotypes in canine atopic dermatitis. Vet Dermatol. 2010;22:143–9.
Bizikova P, Pucheu-Haston CM, Eisenschenk MNC, Marsella R, Nuttall T, Santoro D. Role of genetics and the environment in the pathogenesis of canine atopic dermatitis. Vet Dermatol. 2015;26:95.
Hauck V, Hugli P, Meli ML, Rostaher A, Fischer N, Hofmann Lehmann R, et al. Increased numbers of FoxP3-expressing CD4+ CD25+ regulatory T cells in peripheral blood from dogs with atopic dermatitis and its correlation with disease severity. Vet Dermatol. 2016;27:26.
Trzil JE, Reinero CR. Update on feline asthma. Vet Clin Small Anim. 2014;44:91–105.
Buckley L, Nuttall T. Feline eosinophilic granuloma complex(ities): some clinical clarification. J Feline Med Surg. 2012;14:471–81.
Ravens PA, Xu BJ, Vogelnest LJ. Feline atopic dermatitis: a retrospective study of 45 cases (2001–2012). Vet Dermatol. 2014;25:95.
Waly N, Gruffydd-Jones TJ, Stokes CR, Day MJ. The distribution of leucocyte subsets in the small intestine of healthy cats. J Comp Pathol. 2001;124:172–82.
German AJ, Hall EJ, Day MJ. Analysis of leucocyte subsets in the canine intestine. J Comp Pathol. 1999;120:129–45.
German AJ, Hall EJ, Day MJ. Immune cell populations within the duodenal mucosa of dogs with enteropathies. J Vet Intern Med. 2001;15:14–25.
Waly NE, Stokes CR, Gruffydd-Jones TJ, Day MJ. Immune cell populations in the duodenal mucosa of cats with inflammatory bowel disease. J Vet Intern Med. 2004;18:816–25.
Peters IR, Helps CR, Calvert EL, Hall EJ, Day MJ. Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. J Vet Intern Med. 2005;19:644–53.
Schmitz S, Garden OA, Werling D, Allenspach K. Gene expression of selected signature cytokines of T cell subsets in duodenal tissues of dogs with and without inflammatory bowel disease. Vet Immunol Immunopathol. 2012;146:87–91.
Van Nguyen N, Taglinger K, Helps CR, Tasker S, Gruffydd-Jones TJ, Day MJ. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR. Vet Immunol Immunopathol. 2006;113:404–14.
Kathrani A, House A, Catchpole B, Murphy A, German A, Werling D, et al. Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogs. PLoS One. 2010;5:e15740.
Kathrani A, Lee H, White C, Catchpole B, Murphy A, German A, et al. Association between nucleotide oligomerization domain two (NOD2) gene polymorphisms and canine inflammatory bowel disease. Vet Immunol Immunopathol. 2014;161:32–41.
Freiche V, Faucher MR, German AJ. Can clinical signs, clinicopathological findings and abdominal ultrasonography predict the site of histopathological abnormalities of the alimentary tract in cats? J Feline Med Surg. 2016;18:118–28.
Barrs V, Beatty J. Feline alimentary lymphoma: 1. Classification, risk factors, clinical signs and non-invasive diagnostics. J Feline Med Surg. 2012;14:182–90.
DeBey MC. Primary immunodeficiencies of dogs and cats. Vet Clin Small Anim. 2010;40:425–38.
Abitbol M, Bosse P, Thomas A, Tiret L. A deletion in FOXN1 is associated with a syndrome characterized by congenital hypotrichosis and short life expectancy in Birman cats. PLoS One. 2015;10:e0120668.
Roychoudhur R, Eil RL, Restifo NP. The interplay of effector and regulatory T cells in cancer. Curr Opin Immunol. 2015;33:101–11.
Kitamura T, Qian B-Z, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15:73–86.
Killick DR, Stell AJ, Catchpole B. Immunotherapy for canine cancer - is it time to go back to the future? J Small Anim Pract. 2015;56:229–41.
Gruntzig K, Graf R, Hassig M, Welle M, Meier D, Lott G, et al. The Swiss canine cancer registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol. 2015;152:161–71.
Graf R, Gruntzig K, Hassig M, Axhausen KW, Fabrikant S, Welle M, et al. Swiss feline cancer registry: a retrospective study of the occurrence of tumours in cats in Switzerland from 1965 to 2008. J Comp Pathol. 2015;153:266–77.
Hartmann K, Day MJ, Thiry E, Lloret A, Frymus T, Addie D, et al. Feline injection site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg. 2015;17:606–13.
Dobson JM. Predispositions to cancer in pedigree dogs. ISRN Vet Sci. 2013;2013:941275.
Moore PF. A review of histiocytic diseases of dogs and cats. Vet Pathol. 2014;51:167–84.
Murphy S. Mammary tumours in dogs and cats. In Pract. 2008;30:334–9.
Melville K, Smith KC, Dobromylskyj MJ. Feline cutaneous mast cell tumours: a UK-based study comparing signalment and histological features with long-term outcomes. J Feline Med Surg. 2015;17:486–93.
Hariharan H, Gibson K, Peterson R, Frankie M, Matthew V, Daniels J, et al. Staphylococcus pseudintermedius and Staphylococcus schleiferi subspecies coagulans from canine pyoderma cases in Grenada, West Indies, and their susceptibility to beta-lactam drugs. Vet Med Int. 2014;2014:850126.
Hartmann K, Egberink H, Pennisi MG, Lloret A, Addie D, Belak S, et al. Leptospira species infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:576–81.
Schuller S, Francey T, Hartmann K, Hugonnard M, Kohn B, Nally JE, et al. European consensus statement on leptospirosis in dogs and cats. J Small Anim Pract. 2015;56:159–79.
Weis S, Rettinger A, Bergmann M, Llewellyn JR, Pantchev N, Straubinger RK, et al. Detection of Leptospira DNA in urine and presence of specific antibodies in outdoor cats in Germany. J Feline Med Surg. 2016. doi: 10.1177/1098612X16634389.
Sharman MJ, Mansfield CS. Sinonasal aspergillosis in dogs: a review. J Small Anim Pract. 2012;53:434–44.
Gunn-Moore DA, McFarland SE, Brewer JI, Crawshaw TR, Clifton-Hadley RS, Kovalik M, et al. Mycobacterial disease in cats in Great Britain: I. Culture results, geographical distribution and clinical presentation of 339 cases. J Feline Med Surg. 2011;13:934–44.
Barrs VR, Talbot JJ. Feline aspergillosis. Vet Clin Small Anim. 2014;44:51–73.
Jo H, Choi H, Choi M-K, Song N, Kim J-H, Oh J-W, et al. Identification and classification of endogenous retroviruses in the canine genome using degenerative PCR and in-silico data analysis. Virology. 2012;422:195–204.
Tarlinton RE, Barfoot HKR, Allen CE, Brown K, Gifford RJ, Emes RD. Characterisation of a group of endogenous gammaretroviruses in the canine genome. Vet J. 2013;196:28–33.
Kuiken T, Rimmelzwaan G, van Riel D, van Amerongen G, Baars M, Fouchier R, et al. Avian H5N1 influenza in cats. Science. 2004;306:241.
Lei N, Yuan Z-G, Huang S-F, Zhang D-W, Zhang A-G, Huang B-H, et al. Transmission of avian-origin canine influenza viruses A (H3N2) in cats. Vet Microbiol. 2012;160:481–3.
Martina BEE, Haagmans BL, Kuiken T, Fouchier RAM, Rimmelzwaan GF, van Amerongen G, et al. SARS virus infection of cats and ferrets. Nature. 2003;425:915.
Kang YM, Kim HM, Ku KB, Park EH, Yum J, Seo SH. H3N2 canine influenza virus causes severe morbidity in dogs with induction of genes related to inflammation and apoptosis. Vet Res. 2013;44:92.
Ikeda Y, Nakamura K, Miyazawa T, Chen M-C, Kuo T-F, Lin JA, et al. Seroprevalence of canine distemper virus in cats. Clin Diag Lab Immunol. 2001;8:641–4.
Walker D, Abbondati E, Cox AL, Mitchell GBB, Pizzi R, Sharp CP, et al. Infectious canine hepatitis in red foxes (Vulpes vulpes) in wildlife rescue centres in the UK. Vet Rec. 2016;178:421.
Nakamura K, Sakamoto M, Ikeda Y, Sato E, Kawakami K, Miyazawa T, et al. Pathogenic potential of canine parvovirus types 2a and 2c in domestic cats. Clin Diag Lab Immunol. 2001;8:663–8.
Gomes De Almeida Leal C, Roatt BM, de Oliveira Aguiar-Soares RD, Carneiro CM, Giunchetti RC, Teixeira-Carvalho A, et al. Immunological profiles of resistance and susceptibility in naturally infected dogs by Leishmania infantum. Vet Parasitol. 2014;205:472–82.
Pennisi MG, Cardoso L, Baneth G, Bordeau P, Koutinas A, Miro G, et al. LeishVet update and recommendations on feline leishmaniosis. Parasit Vectors. 2015;8:302.
Soares CSA, Duarte SC, Sousa SR. What do we know about feline leishmaniosis? J Feline Med Surg. 2016;18:435–42.
Yuhki N, Beck T, Stephens R, Neelam B, O’Brien SJ. Comparative genomic structure of human, dog, and cat MHC: HLA, DLA, and FLA. J Hered. 2007;98:390–9.
Ostrander EA, Wayne RK. The canine genome. Genome Res. 2005;15:1706–16.
Leroy G, Verrier E, Meriaux JC, Rognon X. Genetic diversity of dog breeds: between-breed diversity, breed assignation and conservation approaches. Anim Genet. 2009;40:333–43.
Vaysse A, Ratnakumar A, Derrien T, Axelsson E, Peilberg GR, Sigurdsson S, et al. Identification of genomic regions associated with pheontypic variation between dog breeds using selection mapping. PLoS Genet. 2011;7:e1002316.
Mellanby RJ, Ogden R, Clements DN, French AT, Gow AG, Powell R, et al. Population structure and genetic heterogeneity in popular dog breeds in the UK. Vet J. 2013;196:92–7.
Alhaddad H, Khan R, Grahn RA, Gandolfi B, Mullikin JC, Cole SA, et al. Extent of linkage disequilibrium in the domestic cat, Felis silvestris catus, and its breeds. PLoS One. 2013;8:e53537.
Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535:65–74.
Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535:75–84.
Batt RM, Rutgers HC, Sancak AA. Enteric bacteria: friend or foe? J Small Anim Pract. 1996;37:261–7.
Suchodolski JS. Intestinal microbiota of dogs and cats: a bigger world than we thought. Vet Clin Small Anim. 2011;41:261–72.
Tun HM, Brar MS, Khin N, Jun L, Hui RK-H, Dowd SE, et al. Gene-centric metagenomics analysis of feline intestinal microbiome using 454 junior pyrosequencing. J Microbiol Methods. 2012;88:369–76.
Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol. 2011;76:301–10.
Honneffer JB, Minamoto Y, Suchodolski JS. Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs. World J Gastroenterol. 2014;20:16489–97.
Suchodolski JS, Foster ML, Sohail MU, Leutenegger C, Queen EV, Steiner JM, et al. The fecal microbiome in cats with diarrhea. PLoS One. 2015;5:e0127378.
Morchon R, Carreton E, Gonzalez-Miguel J, Mellado-Hernandez I. Heartworm disease (Dirofilaria immitis) and their vectors in Europe – new distribution trends. Front Physiol. 2012;3:196.
Solano-Gallego L, Baneth G. Babesiosis in dogs and cats - expanding parasitological and clinical spectra. Vet Parasitol. 2011;181:48–60.
Hartmann K, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, et al. Babesiosis in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:643–6.
Sherrill MK, Cohn LA. Cytauxzoonosis: diagnosis and treatment of an emerging disease. J Feline Med Surg. 2015;17:940–8.
Weingart C, Tasker S, Kohn B. Infection with haemoplasma species in 22 cats with anaemia. J Feline Med Surg. 2016;18:129–36.
Krupka I, Straubinger RK. Lyme borreliosis in dogs and cats: background, diagnosis, treatment and prevention of infections with Borrelia burgdorferi sensu stricto. Vet Clin Small Anim. 2010;40:1103–19.
Pennisi MG, Marsilio F, Hartmann K, Lloret A, Addie D, Belak S, et al. Bartonella species infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:563–9.
Little SE. Ehrlichiosis and anaplasmosis in dogs and cats. Vet Clin Small Anim. 2010;40:1121–40.
Savidge C, Ewing P, Andrews J, Aucoin D, Lappin MR, Moroff S. Anaplasma phagocytophilum infection of domestic cats: 16 cases from the northeastern USA. J Feline Med Surg. 2016;18:85–91.
McElroy KM, Blagburn BL, Breitschwerdt EB, Mead PS, McQuiston JH. Flea-associated zoonotic diseases of cats in the USA: bartonellosis, flea-borne rickettsioses, and plague. Trends Parasitol. 2010;26:197–204.
The material explored in this review was first presented as an oral communication to the 11th Companion Vector-Borne Diseases World Forum in Miami, Florida, May 9th to 12th, 2016. The publication charges for this manuscript have been kindly sponsored by Bayer Animal Health.
There was no funding related to preparation of this review article. The publication charges for this manuscript have been kindly sponsored by Bayer Animal Health.
Availability of data and material
The author declares that he has no competing interests.
Consent for publication
Ethics approval and consent to participate
About this article
Cite this article
Day, M.J. Cats are not small dogs: is there an immunological explanation for why cats are less affected by arthropod-borne disease than dogs?. Parasites Vectors 9, 507 (2016). https://doi.org/10.1186/s13071-016-1798-5